Chief Executive Officer
Mon, Aug 15, 2022
Aug 15
exercised or converted securities in DAWN
10,686 shares @ $0.00
Increased holdings by +0.90%
Option Exercise
Sale tied to a same-time option exercise
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology